Buscar
Mostrando ítems 1-10 de 46
Chimerism Interpretation With A Highly Sensitive Quantitative Pcr Method: 6 Months Median Latency Before Chimerism Drop Below 0.1%
(NATURE PUBLISHING GROUPLONDON, 2016)
Chimerism Interpretation With A Highly Sensitive Quantitative Pcr Method: 6 Months Median Latency Before Chimerism Drop Below 0.1%
(Nature Publishing GroupLondon, 2016)
Alloreactive Regulatory T Cells Allow the Generation of Mixed Chimerism and Transplant Tolerance
(Frontiers Media, 2015)
The induction of donor-specific transplant tolerance is one of the main goals of modern immunology. Establishment of a mixed chimerism state in the transplant recipient has proven to be a suitable strategy for the induction ...
Dendritic cell chimerism in oral mucosa of transplanted patients affected by graft-versus-host disease
(John Wiley & Sons, 2016)
ObjectiveGraft-versus-host disease (GVHD) is one of the main complications after haematopoietic stem cell transplantation. Clinical features of GVHD include either an acute (aGVHD) or a chronic (cGVHD) condition that affects ...
Avaliação do valor prognóstico da detecção do status quimérico de pacientes após o transplante alogênico de células progenitoras hematopoéticas
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008-01-01)
Este trabalho teve por objetivo correlacionar o status quimérico de pacientes pós -TCPH alogênico com parâmetros clínicos, para avaliar o valor preditivo dos achados laboratorias de quimerismo. Amostras de sangue de 98 ...
Avaliação do valor prognóstico da detecção do status quimérico de pacientes após o transplante alogênico de células progenitoras hematopoéticas
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008-01-01)
Este trabalho teve por objetivo correlacionar o status quimérico de pacientes pós -TCPH alogênico com parâmetros clínicos, para avaliar o valor preditivo dos achados laboratorias de quimerismo. Amostras de sangue de 98 ...
Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
(Associação Paulista de Medicina - APM, 2009-09-01)
CONTEXT AND OBJECTIVE: Non-myeloablative hematopoietic stem cell transplantation (NMA-HSCT) is performed in onco-hematological patients who cannot tolerate ablative conditioning because of older age or comorbidities. This ...
Avaliação do valor prognóstico da detecção do status quimérico de pacientes após o transplante alogênico de células progenitoras hematopoéticas
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2014)
Hematopoietic Chimera in a Male Blood Donor and His Dizygotic Twin Sister
(Karger, 2019-08-01)
Twin hematopoietic chimera in humans is a phenomenon that was discovered accidentally and the prevalence of which remains unclear. The resolution of chimera cases requires studying family medical records, data analysis, ...